United Therapeutics Corporation · NASDAQ:UTHR

Vanguard Capital Management LLC reported a 5.19% stake in United Therapeutics Corporation (Schedule 13G)

Event Mar 31, 2026 · Filed Apr 30, 2026

Vanguard Capital Management LLC reported a 5.19% stake in United Therapeutics Corporation, 2,278,348 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).

Stake
5.19%
Shares
2,278,348
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Vanguard Capital Management5.19%2,278,348

Source

View original at SEC

Related